Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06815263 · ClinicalTrials.gov registry record · NA

Listener Training for Improved Intelligibility of People With Parkinson's Disease

A NA study of Dysarthria, Hypokinetic, sponsored by Utah State University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT06815263: Recruiting NA study of Dysarthria, Hypokinetic, sponsored by Utah State University.

NCT06815263 is a NA study of Dysarthria, Hypokinetic that is actively recruiting participants, run by Utah State University. The registered enrollment target is 360 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06815263, a NA study of Dysarthria, Hypokinetic, is actively recruiting participants, sponsored by Utah State University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners. This translational work will establish a new realm of clinical practice in which the intelligibility impairments in PD are addressed by training partners to better understand dysarthric speech, thus elevating communication outcomes and participation in daily life.

Primary Outcome

Percent words correct (PWC)

Conditions Studied

Interventions

  • BEHAVIORAL Listener Training

Study Locations (2)

Florida

  • Florida State University - Tallahassee

Utah

  • Utah State University - Logan

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-03-26
Est. Completion 2029-05
Phase NA
Utah State University

27 total trials

What NCT06815263 shows while recruiting

NCT06815263 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Dysarthria, Hypokinetic appearing as the primary indexed condition, and to 1 intervention - of which Listener Training is the first listed.

NCT06815263 reports a single indexed study location in Florida, Utah.

Frequently Asked Questions

What is clinical trial NCT06815263 about?

NCT06815263 is a clinical study titled "Listener Training for Improved Intelligibility of People With Parkinson's Disease". Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to estab...

What is the current status of trial NCT06815263?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-03-26. Estimated completion is 2029-05.

What conditions does trial NCT06815263 study?

This clinical trial studies the following conditions: Dysarthria, Hypokinetic.

What interventions are being tested in trial NCT06815263?

The interventions under investigation include: Listener Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06815263?

This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06815263 being conducted?

This trial has 2 study locations across Florida, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06815263's enrollment target sits among peer trials

360 284th of 2000 higher than 1,713 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

  • NCT04160000 · 360 participants · Phase 4

    Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06815263, the US trial registry maintained by the National Library of Medicine. NCT06815263 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.